NCT03402503 - Safety, and Efficacy of a New Buccal Film of Montelukast in Patients With Mild to Moderate Alzheimer's Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 26, 2018

Primary Completion Date

March 13, 2024

Study Completion Date

April 3, 2024

Conditions

Alzheimer Disease

Interventions

DRUG

Montelukast buccal film

Film with active investigational product (montelukast) inserted and applied on inner cheek

OTHER

Placebo buccal film

Film with placebo (no active drug) inserted and applied on inner cheek

Trial Locations (12)

Vancouver Island Health Authority, Victoria

Centricity Research (formerly True North Clinical Research), Halifax

Centricity Research (formerly True North Clinical Research), New Minas

Bruyère Research Institute, Ottawa

Recherches Neuro-Hippocampe, Ottawa

Kawartha Centre - Redefining Healthy Aging, Peterborough

Gerontion Research Inc., Toronto

Baycrest, Toronto

Recherche Neuro-Hippocampe, Gatineau

Centre hospitalier universitaire de Québec -Université Laval, Québec

Centre de recherche sur le vieillissement, CIUSSS de l'Estrie-CHUS, Sherbrooke

Diex Recherche Sherbrooke Inc., Sherbrooke